
Amprius Technologies, Inc. (NYSE:AMPX – Free Report) – HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Amprius Technologies in a note issued to investors on Thursday, August 6th. HC Wainwright analyst A. Dayal now expects that the company will post earnings of $0.16 per share for the year, down from their prior forecast of $0.18. The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.08) per share.
Other equities analysts have also issued research reports about the company. JonesTrading started coverage on Amprius Technologies in a research note on Friday, July 10th. They set a “buy” rating and a $30.00 target price on the stock. Zacks Research raised Amprius Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Northland Securities set a $24.00 price target on shares of Amprius Technologies in a research report on Monday, May 11th. Wall Street Zen cut shares of Amprius Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Finally, Clear Str began coverage on shares of Amprius Technologies in a research note on Tuesday, June 2nd. They issued a “strong-buy” rating and a $33.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Amprius Technologies has an average rating of “Moderate Buy” and a consensus price target of $22.50.
Amprius Technologies Trading Down 4.5%
Shares of NYSE AMPX opened at $11.20 on Friday. The stock has a market capitalization of $1.59 billion, a PE ratio of -38.61 and a beta of 2.33. Amprius Technologies has a twelve month low of $6.36 and a twelve month high of $24.23. The stock has a fifty day simple moving average of $13.65 and a 200-day simple moving average of $14.93.
Amprius Technologies (NYSE:AMPX – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative return on equity of 13.23% and a negative net margin of 35.16%.The firm had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million.
Hedge Funds Weigh In On Amprius Technologies
Several hedge funds and other institutional investors have recently made changes to their positions in AMPX. Oppenheimer & Co. Inc. grew its holdings in Amprius Technologies by 47.7% during the 4th quarter. Oppenheimer & Co. Inc. now owns 442,090 shares of the company’s stock worth $3,488,000 after acquiring an additional 142,751 shares in the last quarter. Stephens Investment Management Group LLC raised its holdings in shares of Amprius Technologies by 33.1% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,441,698 shares of the company’s stock valued at $11,375,000 after purchasing an additional 358,791 shares in the last quarter. Hussman Strategic Advisors Inc. acquired a new stake in shares of Amprius Technologies in the 4th quarter valued at $1,657,000. Vanguard Group Inc. lifted its position in shares of Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock worth $56,245,000 after purchasing an additional 616,037 shares during the last quarter. Finally, UBS Group AG lifted its position in shares of Amprius Technologies by 35.5% during the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock worth $16,561,000 after purchasing an additional 549,892 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company’s stock.
Insider Buying and Selling
In other news, CEO Thomas M. Stepien sold 2,000 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $20.97, for a total value of $41,940.00. Following the sale, the chief executive officer directly owned 625,625 shares in the company, valued at approximately $13,119,356.25. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald R. Dixon sold 85,000 shares of Amprius Technologies stock in a transaction on Monday, June 15th. The shares were sold at an average price of $17.17, for a total value of $1,459,450.00. Following the completion of the transaction, the director owned 359,380 shares of the company’s stock, valued at approximately $6,170,554.60. This trade represents a 19.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 310,144 shares of company stock valued at $5,049,997 in the last three months. 5.10% of the stock is currently owned by insiders.
Amprius Technologies News Summary
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Record Q2 revenue reached approximately $34 million, representing 125% year-over-year growth and exceeding expectations. Management also raised its outlook, forecasting at least $140 million in 2026 revenue and a gross margin of at least 28%. Amprius forecasts 2026 revenue and gross margin
- Positive Sentiment: Demand for Amprius’ SiCore batteries is expanding, particularly in defense drones. The company is also increasing NDAA-compliant manufacturing capacity, improving its ability to pursue U.S. defense-related contracts. Q2 earnings call highlights
- Positive Sentiment: Coverage has improved after Zacks Research upgraded AMPX from “strong sell” to “hold.” Reports also cited bullish analyst targets, increased institutional buying and elevated short interest, which could amplify a rebound if operating results continue to improve. Zacks Research
- Neutral Sentiment: The earnings release produced a revenue beat and prompted a sharp initial rally, but the stock’s subsequent volatility suggests investors may be taking profits or demanding more evidence that the upgraded guidance is achievable. Amprius trading after earnings beat
- Negative Sentiment: Amprius remains unprofitable, with a quarterly loss and negative margins. Continued cash needs, production scale-up requirements and dependence on converting battery demand into contracts could limit the stock’s upside despite the strong growth outlook. Amprius Q2 earnings report
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Recommended Stories
- Five stocks we like better than Amprius Technologies
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
